Luxcel Biosciences Ltd

At present our main focus is on the novel platform technology - cell-respirometric screening (CRS), based on the optical oxygen sensing approach. We are commercialising our CRS technology by developing a range of advanced products and applications

Further Information: http://www.luxcel.com